Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0983 per EA under NDC 72888009401. Its NADAC has been published 173 times since May 3, 2023.
FDA first approved this application on Feb 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888009401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA216211FDA Approved
2/23/2022
TE Code
AB
On Market Since
2/23/2022
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 173 times since May 3, 2023, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0983 per EA |
|---|---|
| All-time high | $0.1065 (Feb 14, 2024) |
| All-time low | $0.0721 (Nov 20, 2024) |
| 52-week high | $0.0983 |
| 52-week low | $0.0915 |
| Median price | $0.0959 |
| Average price | $0.0933 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 173 |
| Tracking since | May 3, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by Advagen Pharma Ltd., is $0.0983 per EA (NDC 72888009401), effective Aug 19, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has risen 10.8%. It has been tracked across 173 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Since May 3, 2023, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1065 (Feb 14, 2024), with a median of $0.0959 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0963 per EA — about 2% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 72888009401) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.